COVID-19: physIQ is answering the call for health systems and clinical trials. Click here to learn more.
 

Resources

The industries we serve are fast moving and complex with changing regulations, technology and innovations. The physIQ team is here to help you make sense of it all. Check back often for updated resources.

Oncology Study with Janssen

Chris Economos of physIQ and Bert Hartog of Janssen discuss how they are working with HagaHospital (The Hague, Netherlands) to deploy accelerateIQTM to detect physiological anomalies during and after anti-cancer treatment. Funded by Janssen Pharmaceuticals, the study is evaluating how clinicians can leverage this technology to proactively identify and manage adverse events that may result from chemotherapy and immunotherapy, with potential to establish safety-related digital biomarkers. 

TOPICS: Real-World Data and Analytics

AUDIENCE: Clinical Trials

FEATURED RESOURCES

Gary Conkright interviewed about the COVID-19 crisis by WGN Radio
Gary Conkright interviewed about the COVID-19 crisis by WGN Radio

Gary Conkright, physIQ's CEO, was interviewed by Mark Carman from WGN Radio 720 about the current COVID-19 crisis and how technology like physIQ's can help, similar to how it helped the Ebola crisis back in 2015.

Implementing New Clinical Innovations
Implementing New Clinical Innovations

When adopting new innovations in the clinical space, your success can be supported by considering the process a three legged stool...

Oncology Study with Janssen
Oncology Study with Janssen

PhysIQ partnered with Janssen to deploy accelerateIQTM to detect physiological anomalies during and after anti-cancer treatment. 

Contact us and transform the future of real-world patient insight.

At physIQ, we welcome the opportunity to speak with potential customers, partners or anyone with an interest in learning more about the transformative potential of our technology.

Contact Us